Inspire Medical Systems (INSP) director receives stock in lieu of cash fees

Rhea-AI Filing Summary

Inspire Medical Systems director reports stock award

Director Casey M. Tansey reported receiving 181 shares of Inspire Medical Systems common stock on January 15, 2026, coded as an acquisition. The shares were valued at $96.47 each and were received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. Following this award, Tansey holds 22,416 common shares directly.

In addition, two family trusts each hold 500 Inspire Medical Systems common shares, identified as the Kimberly Tansey Irrevocable Trust and the Kylie Tansey Irrevocable Trust, reported as indirect beneficial ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tansey Casey M

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		A		181(1)	A	$96.47	22,416	D
Common Stock								500	I	By Family Trust(2)
Common Stock								500	I	By Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

2. Securities held by The Kimberly Tansey Irrevocable Trust.

3. Securities held by The Kylie Tansey Irrevocable Trust.

	/s/ Bryan Phillips, Attorney-in-Fact for Casey M. Tansey	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Inspire Medical Systems (INSP) report for Casey M. Tansey?

Director Casey M. Tansey reported acquiring 181 shares of Inspire Medical Systems common stock on January 15, 2026, as shown on a Form 4 filing.

At what price were the new Inspire Medical Systems (INSP) shares valued?

The 181 shares reported for Casey M. Tansey were valued at $96.47 per share, received as stock in lieu of cash director fees.

How many Inspire Medical Systems (INSP) shares does Casey M. Tansey own after this transaction?

After the reported transaction, Casey M. Tansey directly beneficially owns 22,416 shares of Inspire Medical Systems common stock.

Were the Inspire Medical Systems (INSP) shares part of a compensation plan?

Yes. The filing states the 181 shares were received in lieu of cash fees under the company’s Non-Employee Director Compensation Policy.

What indirect holdings related to Casey M. Tansey in Inspire Medical Systems (INSP) are disclosed?

The filing reports 500 shares held by The Kimberly Tansey Irrevocable Trust and 500 shares held by The Kylie Tansey Irrevocable Trust as indirect beneficial ownership positions.

What is Casey M. Tansey’s role at Inspire Medical Systems (INSP)?

The Form 4 identifies Casey M. Tansey as a director of Inspire Medical Systems, Inc.